skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Transcatheter aortic valve replacement in patients with pure native aortic valve regurgitation: A systematic review and meta‐analysis

Clinical cardiology (Mahwah, N.J.), 2019-01, Vol.42 (1), p.159-166 [Peer Reviewed Journal]

2018 Wiley Periodicals, Inc. ;2019. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0160-9289 ;EISSN: 1932-8737 ;DOI: 10.1002/clc.23103 ;PMID: 30350358

Full text available

Citations Cited by
  • Title:
    Transcatheter aortic valve replacement in patients with pure native aortic valve regurgitation: A systematic review and meta‐analysis
  • Author: Haddad, Abdullah ; Arwani, Remy ; Altayar, Osama ; Sawas, Tarek ; Murad, M. Hassan ; de Marchena, Eduardo
  • Subjects: aortic regurgitation ; Aortic Valve - surgery ; Aortic Valve Insufficiency - mortality ; Aortic Valve Insufficiency - surgery ; Cause of Death - trends ; Global Health ; Humans ; meta‐analysis ; Mortality ; Review ; Surgeons ; Systematic review ; transcatheter aortic valve replacement ; Transcatheter Aortic Valve Replacement - methods ; Treatment Outcome
  • Is Part Of: Clinical cardiology (Mahwah, N.J.), 2019-01, Vol.42 (1), p.159-166
  • Description: This systematic review and meta‐analysis sought to summarize the available evidence on the use of transcatheter aortic valve replacement (TAVR) in patients with Native Aortic Valve Regurgitation (NAVR) and compare outcomes between first and second generation valves. Owing to the improvements in transcatheter heart valve design and procedural success, TAVR has become increasingly performed in broader aortic valve pathologies. We searched Medline, Embase, Cochrane, and Scopus databases from 2007 to 2018 and performed a systematic review on reports with at least 10 patients with aortic valve regurgitation undergoing TAVR procedure. The main outcome of interest was all‐cause mortality at 30 days. A total of 638 patients across 12 studies were included. Mean age ranged from 68 to 84. Society of Thoracic Surgeons score ranged from 5.4% to 13.1% and Logistic EuroSCORE ranged from 18.2% to 33%. The incidence rate of all‐cause mortality at 30 days was found to be 11% (95% CI 7%‐16%; I2 = 20.86%). All‐cause mortality at 30 days for first generation valves had an incidence rate of 15% (95% CI 10%‐20%; I2 = 10%) compared to 7% (95% CI 3%‐13%; I2 = 37%) in second generation valves with subgroup interaction analysis P = 0.059. Device success incidence rate in second generation valves was 92% (95% CI 83%‐99%; I2 = 67%) vs 68% (95% CI 59%‐77%; I2 = 53%) in first generation valves with P = 0.001. TAVR appears to be a feasible treatment choice for NAVR patients at high risk for surgical valve replacement. Second generation valves show promising results in terms of short‐term outcomes.
  • Publisher: New York: Wiley Periodicals, Inc
  • Language: English
  • Identifier: ISSN: 0160-9289
    EISSN: 1932-8737
    DOI: 10.1002/clc.23103
    PMID: 30350358
  • Source: MEDLINE
    PubMed Central
    ProQuest Central
    DOAJ Directory of Open Access Journals
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait